BlackRock Innovation and Growth Term Trust (BTX)
NYSE: BTX · Real-Time Price · USD
6.33
-0.11 (-1.71%)
At close: Mar 28, 2025, 4:00 PM
6.42
+0.09 (1.43%)
After-hours: Mar 28, 2025, 8:00 PM EDT
Company Description
BlackRock Technology and Private Equity Term Trust is a mutual fund launched by BlackRock, Inc. The fund is managed by BlackRock Advisors, LLC. BlackRock Technology and Private Equity Term Trust is domiciled in the United States.
BlackRock Innovation and Growth Term Trust
| Country | United States |
| Industry | Biotechnology |
| Sector | Healthcare |
Contact Details
Address: 50 Hudson Yards New York, New York 10001 United States | |
| Phone | 212 810 5300 |
Stock Details
| Ticker Symbol | BTX |
| Exchange | NYSE |
| Reporting Currency | USD |
| CIK Code | 0001836057 |
| CUSIP Number | 09066L170 |
| ISIN Number | US1140821000 |
| Employer ID | 94-3127919 |
Key Executives
| Name | Position |
|---|---|
| Dr. Matthew Angel Ph.D. | Chief Executive Officer and Director |
| Dr. Roger Sidhu M.D. | Chief Medical Officer |
| Andrew C. Jackson | Chief Financial Officer |
| Dr. Monil Shah M.B.A., Pharm.D. | Chief Operating Officer |
| Sandra M. Gurrola | Principal Accounting Officer and Vice President of Finance |
| Lynn Sadowski Mason M.S. | Executive Vice President of Clinical Operations |
| Susan McClatchey | Vice President and Head of Quality |